|
Volumn 287, Issue 18, 2002, Pages 2360-2361
|
Hormone replacement therapy and risk of breast cancer [2]
a a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ESTROGEN;
GESTAGEN;
ORAL CONTRACEPTIVE AGENT;
BREAST CARCINOGENESIS;
BREAST CARCINOMA;
CANCER INCIDENCE;
CANCER RISK;
CANCER SUSCEPTIBILITY;
FEMALE;
HIGH RISK POPULATION;
HORMONE SUBSTITUTION;
HUMAN;
LETTER;
MENOPAUSE;
OVARIECTOMY;
PRIORITY JOURNAL;
RISK ASSESSMENT;
UNITED KINGDOM;
BREAST TUMOR;
ESTROGEN THERAPY;
NOTE;
RISK FACTOR;
DRUG UTILIZATION;
STATISTICS;
BREAST NEOPLASMS;
ESTROGEN REPLACEMENT THERAPY;
FEMALE;
HUMANS;
MENOPAUSE;
OVARIECTOMY;
RISK FACTORS;
CONTRACEPTIVES, ORAL, HORMONAL;
DRUG UTILIZATION;
|
EID: 0037042405
PISSN: 00987484
EISSN: None
Source Type: Journal
DOI: 10.1001/jama.287.18.2360 Document Type: Letter |
Times cited : (3)
|
References (0)
|